Kineret GMP Warning Letter Prompts Changes To Internal Amgen Inspections
Executive Summary
Amgen is making global changes to its internal inspection procedures in response to a warning letter from FDA
You may also be interested in...
Enbrel, Prolia Suffer FDA’s Combination Punch On Device Components
Amgen did not follow proper procedures when it switched from one Enbrel vial adapter to another, FDA says, a change that led to an uptick in product complaints.
GMP Warning Letter Downward Trend Accelerates; Few Oral Solids Get Cited
The number of warning letters issued by FDA to pharmaceutical firms for good manufacturing practices fell by half in fiscal 2003
GMP Warning Letter Downward Trend Accelerates; Few Oral Solids Get Cited
The number of warning letters issued by FDA to pharmaceutical firms for good manufacturing practices fell by half in fiscal 2003